CCR5 and myeloid sarcoma: In conclusion, although a pathogenic role of CCL2/CCR2 as well as of CCR5 and its ligands in MS is widely recognized, mainly due to their role in leukocyte recruitment to active lesions and amplification of the local inflammatory response, the role of these chemokine/receptors axes in MS is likely much more complicated.